Search
honey_and_cinnamon_cookies_recipe.pdf
Proven and trustworthy
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
Blood Eosinophils and COPD
Prevalence of VTE in the US and Europe.pdf
Effect_of_Tiotropium_and_Salmeterol_in_COPD_Patients_With .pdf
cancer_statistics_and_incidence_rates.pdf
infographic.bp_goals_and_measurement_0.pdf
erbb_family_blockade_and_afatinib.pdf
Respiratory Research and Development Timeline.pdf
Blood Pressure Goals and Measurement.pdf
Unbranded illustrated factsheet.pdf
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
A career at the intersection of science and marketing
A member of the Animal Health digital marketing team, our colleague Missy talks about her purpose to bring transformative technologies to the vet community
Patient centricity and site centricity in clinical trials
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Veterinarians go beyond: animal care and veterinary medicine
We surveyed over 1000 veterinarians from six countries. Did you know that only 49% of respondents think that the veterinary profession is appreciated?
Breakthrough Designation granted in US and China
SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
Telling my story AF and DVT PE Patient Voices
Informed decision and safe use of medications
Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim
Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms.
Nerandomilast (BI 1015550)
Nerandomilast (BI 1015550)
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Mental health: a $1 trillion burden demanding policy action
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.